Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × motexafin gadolinium × Clear all

NCT00096837 2006-06-08

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell